B of A Securities Reiterates Buy Rating on UnitedHealth Group
B of A Securities maintains a buy rating on UnitedHealth Group with a $475 price target, a 11.01% upside from the current price.
Key Points
- B of A Securities reiterated its buy rating on UnitedHealth Group (NYSE:UNH) with a price target of $475.
- B of A Securities's $475 price target implies 11.01% upside from UnitedHealth Group Incorporated's ($UNH) current $427.89 share price.
- Shares of UNH traded near $409.25 on Wednesday, with a market cap of $369.3 billion and a P/E ratio of 30.65.
- Recent insider activity included sales by executives, while analysts from multiple firms maintained buy ratings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
B of A Securities has reiterated its buy rating on UnitedHealth Group Incorporated (NYSE:UNH), setting a price target of $475. This move from analyst Kevin Fischbeck was announced on June 24, 2026. Shares of UnitedHealth traded near $409.25 on Wednesday.
B of A Securities vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
UnitedHealth Group Incorporated Stock Up 8.9%
Shares of NYSE:UNH were trading at approximately $409.25 on Wednesday. UnitedHealth Group has a market capitalization of about $369.3 billion. The company sports a P/E ratio of 30.65 and a forward P/E of 19.43. With a beta of 0.65, the stock has seen a 52-week range between $234.60 and $415.98. Its 50-day moving average stands at $372.67, while the 200-day moving average is $333.55.
$UNH price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
UnitedHealth Group reported revenue of $449.71 billion with a growth rate of 2%. The company's net margin is 2.68%, and it has a return on equity of 12.18%. The next earnings report is expected on July 16, 2026.
Dividend
The company offers an annual dividend rate of $9.28, yielding 2.31%. Its dividend payout ratio is 66.57%.
Insider Buying and Selling at UnitedHealth Group Incorporated
Recent insider activity at UnitedHealth Group includes several transactions. On June 5, 2026, Patrick Hugh Conway, CEO of Optum, sold 687 shares at an average price of $399.47. Earlier, on June 3, EVP & Chief Legal Officer Christopher Zaetta sold 134 shares at $377. On June 2, Conway sold another 204 shares at $377.92. These transactions were not under a Rule 10b5-1 plan.
Analysts Set New Price Targets
On June 24, 2026, B of A Securities maintained its buy rating on UnitedHealth Group with a $475 price target. Earlier, on June 17, Leerink Partners also maintained a buy rating with a $462 target. Mizuho and JP Morgan set targets of $460 and $466, respectively, on June 8. The consensus among analysts is a buy rating, with an average target price of $409.77 based on 26 opinions.
About UnitedHealth Group
UnitedHealth Group Incorporated is a healthcare company based in Eden Prairie, Minnesota. It operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. These segments offer a range of health services, including care delivery, pharmacy care services, and consumer-oriented health benefit plans. The company, led by CEO Stephen J. Hemsley, employs approximately 390,000 people.
Bottom Line
B of A Securities' reiteration of a buy rating on UnitedHealth Group with a $475 price target reflects continued confidence in the company's performance. Investors often track such analyst ratings as part of their research process. It's important to remember that these ratings are based on past data and do not necessarily predict future performance.
Get UnitedHealth Group Incorporated alerts
New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.